European Randomized Study of Screening for Prostate Cancer Risk Calculator: External Validation, Variability, and Clinical Significance-Reference-Cited by-同舟云学术

European Randomized Study of Screening for Prostate Cancer Risk Calculator: External Validation, Variability, and Clinical Significance

Published:2017-04 Issue: Volume:102 Page:85-91
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Gómez-Gómez Enrique,Carrasco-Valiente Julia,Blanca-Pedregosa Ana,Barco-Sánchez Beatriz,Fernandez-Rueda Jose Luis,Molina-Abril Helena,Valero-Rosa Jose,Font-Ugalde Pilar,Requena-Tapia Maria José

Funder

Spanish Ministerio de Economía y Competitividad (MINECO), Junta de Andalucía and FEDER

Publisher

Elsevier BV

Subject

Urology

Reference23 articles.

1. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Ferlay;Eur J Cancer,2013

2. Trends in metastatic breast and prostate cancer—lessons in cancer dynamics;Welch;N Engl J Med,2015

3. Biological variation of total prostate-specific antigen: a survey of published estimates and consequences for clinical practice;Soletormos;Clin Chem,2005

4. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013;Heidenreich;Eur Urol,2014

5. Screening for prostate cancer;Ilic;Cochrane Database Syst Rev,2013

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. External Validation of Stockholm3 in a Retrospective German Clinical Cohort;European Urology Focus;2024-08

2. Risk calculators for the detection of prostate cancer: a systematic review;Prostate Cancer and Prostatic Diseases;2024-06-03

3. Comparison between the European Randomized Study for Screening of Prostate Cancer (ERSPC) and Prostate Biopsy Collaborative Group (PBCG) risk calculators: Prediction of clinically significant Prostate Cancer risk in a cohort of patients from Argentina;Actas Urológicas Españolas (English Edition);2023-10

4. Comparación entre las calculadoras de riesgo del European Randomized Study for Screening of Prostate Cancer (ERSPC) y Prostate Biopsy Collaborative Group (PBCG): predicción del riesgo de cáncer de próstata clínicamente significativo en una cohorte de pacientes de Argentina;Actas Urológicas Españolas;2023-08

5. Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination;Cancers;2023-02-11